Skip to Content Skip to Navigation
JDRF is now Breakthrough T1D – welcome to our next chapter. Learn about our evolution.

This is what our Australian type 1 diabetes (T1D) research has achieved so far

Our research impact

83+ projects

In the last decade, we have funded over 83 cutting-edge T1D research projects in Australia

Illustrated research icon

$65 M+

In the last decade, we have invested over $65 million in Australian T1D research projects

An icon of a flask with a dollar sign

450+ researchers

We’ve funded over 450 of the best research minds in Australia and around the world

Blue icon of two researchers wearing lab coats and two beakers. A dotted line between them represents collaboration

2x increase

We’ve doubled the number of T1D clinical trials and studies available for Australians

Icon of a syringe and flask of medicine

10000+ people

Over 10,000 Australians have had access to T1D clinical trials and studies

Illustrated icon depicting research participants

42+ therapeutic targets

Our researchers have identified or studied over 42 therapeutic targets linked to T1D development

Blue icon of a pill and a tablet

"We’re committed to funding T1D research for everyone, at every age and stage of the condition. From those at risk or just diagnosed, to those living with T1D for many years."

Dr Dorota Pawlak, Chief Scientific Officer

Dorota looking at the camera and smiling. She is wearing a navy dress and a white and blue blazer.

Deep dive into our research

Learn more about how we’re changing lives and what you can do to get involved.

Participate in clinical trials and studies

Learn all about clinical trials and studies, including what’s involved, who’s eligible and what the benefits can be.

A doctor and her patient in a hospital or surgery. The patient looks at the doctor, smiling

Information for researchers

Find funding opportunities and information for currently funded researchers.

Image of a female researcher in the lab sitting in front of a microscope. The researcher smiles broadly at the camera

Type 1 Diabetes Clinical Research Network

Discover our primary vehicle for funding T1D research in Australia and the amazing achievements it has produced so far.

Colourful microscopy image of pancreatic islets and blood vessels

Research news

The ultra long-acting insulin Tresiba is now listed on the PBS

Research news

Tresiba, also known as insulin degludec, is now subsidised by the Australian Government.

Tresiba

Tzield updates from the US and UK

Research news

A look at how access to Tzield, the first new therapy for type 1 diabetes (T1D) since insulin, is expanding for more people around the world.

a vial of Tzield

Tzield in Australia: your FAQs answered

Research news

Find answers to frequently asked questions about Tzield, the first drug approved to treat type 1 diabetes (T1D) since insulin.

Jess Kovacs getting Tzield

What is the Eledon trial?

Research developments

Learn about the Eledon trial and why it marks a promising step towards making islet transplants safer and more accessible for people with type 1 diabetes (T1D). 

Close-up view of blue spherical cells.

Type1Screen: Screening for early-stage type 1 diabetes in family members

Research news

Breakthrough T1D funds a program where family members of those with type 1 diabetes can be screened for early signs of the condition.

Photo of a little boy looking at the camera, He has just done a finger prick test and on the table in front of him rests a card with 4 blood spots. He is wearing a bandaid on his right thumb

Tzield is now approved in Australia

Research news

This is the first new therapy approved for T1D in over 100 years, since the discovery of insulin.

A small vial of Tzield

Stay updated

Get the latest type 1 diabetes news

Whether you're interested in research updates, events, our latest resources or advocacy news, there's a Breakthrough T1D newsletter to suit you. Sign up today!






Man with beard wearing a blue shirt holding a little girl with her thumbs up